[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Geovax Labs Inc (GOVX)

Geovax Labs Inc (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,103
  • Shares Outstanding, K 3,473
  • Annual Sales, $ 2,490 K
  • Annual Income, $ -21,460 K
  • EBIT $ -21 M
  • EBITDA $ -20 M
  • 60-Month Beta 3.66
  • Price/Sales 0.88
  • Price/Cash Flow N/A
  • Price/Book 1.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.34
  • Most Recent Earnings $-0.97 on 07/27/26
  • Next Earnings Date 11/12/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-1.02
  • Number of Estimates 2
  • High Estimate $-0.96
  • Low Estimate $-1.09
  • Prior Year $-7.75
  • Growth Rate Est. (year over year) +86.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5900 +2.64%
on 09/01/26
0.8771 -30.95%
on 08/27/26
-0.0756 (-11.10%)
since 07/31/26
3-Month
0.5900 +2.64%
on 09/01/26
2.3400 -74.12%
on 06/02/26
-1.6044 (-72.60%)
since 06/01/26
52-Week
0.5900 +2.64%
on 09/01/26
19.2050 -96.85%
on 09/04/25
-18.0344 (-96.75%)
since 08/29/25

Most Recent Stories

More News
GeoVax Announces a Warrant Inducement Transaction

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Announces Completion of Key GEO-MVA Development Milestones, Positioning Program for Pivotal Phase 3 Clinical Study

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Highlights Newly Published Independent Research Supporting Broader Filovirus Vaccine Strategies and Strategic Value of Its MVA-Based Vaccine Portfolio

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)
GeoVax Reports Second Quarter 2026 Financial Results and Provides Business Update

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

GOVX : 0.6056 (-4.24%)

Business Summary

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

See More

Key Turning Points

3rd Resistance Point 0.6671
2nd Resistance Point 0.6485
1st Resistance Point 0.6271
Last Price 0.6056
1st Support Level 0.5871
2nd Support Level 0.5685
3rd Support Level 0.5471

See More

52-Week High 19.2050
Fibonacci 61.8% 12.0941
Fibonacci 50% 9.8975
Fibonacci 38.2% 7.7009
Last Price 0.6056
52-Week Low 0.5900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.